Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 46 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
ABAT
💬1. ABAT
| 7件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, Propanoate metabolism, Butanoate metabolism, Metabolic pathways, GABAergic synapse 7件: Alanine, aspartate and glutamate metabolism, Valine, leucine and isoleucine degradation, beta-Al ... | Valproic acid
Valproic acid
💬1. ABAT
| Valproic acid | 14件: 2 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256 💬1. ABAT
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 |
ACHE
💬2. ACHE
| 2件: Glycerophospholipid metabolism Glycerophospholipid metabolism, Cholinergic synapse | Galantamine
Galantamine
💬2. ACHE
| Galantamine | 2件: 6 6, 127 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 |
ACHE
💬3. ACHE
| 2件: Glycerophospholipid metabolism Glycerophospholipid metabolism, Cholinergic synapse | Donepezil
Donepezil
💬3. ACHE
| Donepezil | 9件: 5 5, 6, 13, 46, 78, 124, 127, 156, 206 💬3. ACHE
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 |
ADRA1A
💬4. ADRA1A
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion 7件: Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, ... | Amiodarone
Amiodarone
💬4. ADRA1A
| Amiodarone | 2件: 28 28, 127 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 |
ADRA1B
💬5. ADRA1B
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion 6件: Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, ... | Amiodarone
Amiodarone
💬5. ADRA1B
| Amiodarone | 2件: 28 28, 127 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
ADRA1D
💬6. ADRA1D
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion 6件: Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, ... | Amiodarone
Amiodarone
💬6. ADRA1D
| Amiodarone | 2件: 28 28, 127 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 |
ADRB1
💬7. ADRB1
| 11件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy 11件: Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive liga ... | Amiodarone
Amiodarone
💬7. ADRB1
| Amiodarone | 2件: 28 28, 127 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 |
ALDH5A1
💬8. ALDH5A1
| 3件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, Metabolic pathways | Valproic acid
Valproic acid
💬8. ALDH5A1
| Valproic acid | 14件: 2 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256 💬8. ALDH5A1
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 |
CACNA1G
💬9. CACNA1G
| 8件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome 8件: MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis ... | Valproic acid
Valproic acid
💬9. CACNA1G
| Valproic acid | 14件: 2 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256 💬9. CACNA1G
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 |
CACNA1H
💬10. CACNA1H
| 7件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome 7件: MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis ... | Valproic acid
Valproic acid
💬10. CACNA1H
| Valproic acid | 14件: 2 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256 💬10. CACNA1H
|